Waters Wins FDA Clearance for At-Home HPV Cancer Test
MILFORD, Mass., April 8, 2026 Waters Corporation has announced U.S. FDA clearance for its Onclarity™ HPV Self-Collection Kit, enabling...
ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody NSCLC Oncology oncology innovation oncology research Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
MILFORD, Mass., April 8, 2026 Waters Corporation has announced U.S. FDA clearance for its Onclarity™ HPV Self-Collection Kit, enabling...
FRANKLIN LAKES, N.J., Feb. 9, 2026 — Becton, Dickinson and Company (BD) announced the successful completion of the previously...
Milford, Massachusetts, January 20, 2026 — Waters Corporation, a global leader in analytical instruments, separations technologies, and laboratory software,...
